IL166038A0 - Pegylated t20 polypeptide - Google Patents

Pegylated t20 polypeptide

Info

Publication number
IL166038A0
IL166038A0 IL16603803A IL16603803A IL166038A0 IL 166038 A0 IL166038 A0 IL 166038A0 IL 16603803 A IL16603803 A IL 16603803A IL 16603803 A IL16603803 A IL 16603803A IL 166038 A0 IL166038 A0 IL 166038A0
Authority
IL
Israel
Prior art keywords
pegylated
polypeptide
Prior art date
Application number
IL16603803A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL166038A0 publication Critical patent/IL166038A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16603803A 2002-07-24 2003-07-16 Pegylated t20 polypeptide IL166038A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39819502P 2002-07-24 2002-07-24
PCT/EP2003/007710 WO2004013164A1 (en) 2002-07-24 2003-07-16 Pegylated t20 polypeptide

Publications (1)

Publication Number Publication Date
IL166038A0 true IL166038A0 (en) 2006-01-15

Family

ID=31495720

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16603803A IL166038A0 (en) 2002-07-24 2003-07-16 Pegylated t20 polypeptide
IL166038A IL166038A (en) 2002-07-24 2004-12-29 Pegylated t20 polypeptide

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL166038A IL166038A (en) 2002-07-24 2004-12-29 Pegylated t20 polypeptide

Country Status (24)

Country Link
US (1) US7049415B2 (xx)
EP (1) EP1527088B1 (xx)
JP (1) JP4381301B2 (xx)
KR (1) KR100637981B1 (xx)
CN (1) CN100357317C (xx)
AR (1) AR040651A1 (xx)
AT (1) ATE489401T1 (xx)
AU (1) AU2003257467B2 (xx)
BR (1) BR0312889A (xx)
CA (1) CA2493534C (xx)
DE (1) DE60335111D1 (xx)
ES (1) ES2354609T3 (xx)
GT (1) GT200300155A (xx)
HR (1) HRP20050024A2 (xx)
IL (2) IL166038A0 (xx)
MX (1) MXPA05000797A (xx)
NO (1) NO20050066L (xx)
PA (1) PA8577701A1 (xx)
PE (1) PE20040705A1 (xx)
PL (1) PL375254A1 (xx)
RU (1) RU2296769C2 (xx)
TW (1) TW200416225A (xx)
WO (1) WO2004013164A1 (xx)
ZA (1) ZA200500258B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
PT2311432E (pt) 2002-06-07 2015-02-09 Dyax Corp Polipeptídeos de domínio kunitz modificado e sua utilização para a redução de isquemia ou aparecimento de uma resposta inflamatória sistémica associada a um procedimento cirúrgico
US20070020252A1 (en) * 2003-08-29 2007-01-25 Ladner Robert C Modified protease inhibitors
WO2005021557A2 (en) * 2003-08-29 2005-03-10 Dyax Corp. Poly-pegylated protease inhibitors
CN101132812A (zh) * 2004-03-15 2008-02-27 阿拉巴马耐科塔医药公司 Hiv进入抑制剂的聚合物基组合物和结合物
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
PT1869066E (pt) * 2005-04-08 2010-02-03 Lonza Ag Síntese de peptídeo de hélice-alfa sobre resina peg
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
AU2010203712A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
LT2521568T (lt) 2010-01-06 2018-12-10 Dyax Corp. Plazmos kalikreiną surišantys baltymai
CN105713092B (zh) 2011-01-06 2019-09-10 戴埃克斯有限公司 血浆前激肽释放酶结合蛋白
KR102555955B1 (ko) 2014-03-27 2023-07-18 다케다 파머수티컬 컴패니 리미티드 당뇨병성 황반 부종의 치료를 위한 조성물 및 방법
US20160151511A1 (en) 2014-12-02 2016-06-02 Antriabio, Inc. Proteins and protein conjugates with increased hydrophobicity
AU2016366557B2 (en) 2015-12-11 2024-01-25 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US153694A (en) * 1874-08-04 Improvement in clothes-pounders
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
CH690143A5 (de) * 1995-01-27 2000-05-15 Rieter Automotive Int Ag Lambda/4-Schallabsorber.
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
DE69926061T2 (de) * 1998-03-23 2006-06-01 Trimeris Inc. Verfahren und zusammensetzungen zur peptidsynthese (t-20)
EP1135493A2 (en) * 1998-11-30 2001-09-26 Eli Lilly And Company Erythropoietic compounds
PE20010288A1 (es) * 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
KR100488351B1 (ko) * 2001-12-11 2005-05-11 선바이오(주) 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체

Also Published As

Publication number Publication date
PL375254A1 (en) 2005-11-28
TW200416225A (en) 2004-09-01
KR20050027257A (ko) 2005-03-18
ZA200500258B (en) 2006-01-25
CA2493534A1 (en) 2004-02-12
JP4381301B2 (ja) 2009-12-09
IL166038A (en) 2010-11-30
MXPA05000797A (es) 2005-04-19
ATE489401T1 (de) 2010-12-15
CA2493534C (en) 2010-01-26
PA8577701A1 (es) 2004-02-07
AR040651A1 (es) 2005-04-13
HRP20050024A2 (en) 2006-02-28
AU2003257467B2 (en) 2008-02-28
JP2006511455A (ja) 2006-04-06
AU2003257467A1 (en) 2004-02-23
GT200300155A (es) 2004-03-15
RU2296769C2 (ru) 2007-04-10
BR0312889A (pt) 2005-06-14
ES2354609T3 (es) 2011-03-16
EP1527088B1 (en) 2010-11-24
RU2005105577A (ru) 2005-10-27
KR100637981B1 (ko) 2006-10-23
PE20040705A1 (es) 2004-10-14
NO20050066L (no) 2005-04-22
US20040049018A1 (en) 2004-03-11
CN100357317C (zh) 2007-12-26
WO2004013164A1 (en) 2004-02-12
CN1671736A (zh) 2005-09-21
EP1527088A1 (en) 2005-05-04
DE60335111D1 (de) 2011-01-05
US7049415B2 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
IL166038A0 (en) Pegylated t20 polypeptide
AU2003290563A8 (en) Leptin-related peptides
GB0201679D0 (en) Polypeptide variants
GB0100196D0 (en) Peptides
PL375218A1 (en) Recombinant protein variants
EP1614695A4 (en) POLYPEPTIDE
GB0218977D0 (en) Polypeptide
GB0109438D0 (en) Peptides
IL166037A0 (en) Pegylated t1249 polypeptide
GB0223193D0 (en) Polypeptide
GB0202275D0 (en) Peptide
GB0208925D0 (en) Polypeptide
EP1477559A4 (en) NEW POLYPEPTIDE
GB0103517D0 (en) Polypeptide
GB0210746D0 (en) Peptide
GB0202221D0 (en) Novel polypeptide
GB0219980D0 (en) Peptides
GB0101739D0 (en) Novel polypeptide
GB0222181D0 (en) Polypeptide
GB0219720D0 (en) Polypeptide
GB0224896D0 (en) Peptides
GB0213246D0 (en) Peptides
GB0104118D0 (en) Novel polypeptide
GB0107394D0 (en) Novel polypeptide
GB0100039D0 (en) Novel polypeptide